TRPV4 modifies cytoskeleton-related protein to promote the migration and invasion of HCC cells, and alters sc polarity via activating Ca2+-dependent AMPK/MLC/ERM pathway, which increases the adhesion of metastatic HCC cells to blood vessels. Here, MLC1 is linked to hepatocellular carcinoma.